Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- DAL +1.9%, FAST +1.3%
Select Airline stocks trading higher in sympathy with DAL:
- JBLU +1.8%, UAL +1.5%, LUV +1.3%, AAL +1%
Other news:
- CASI +28.4% (Director discloses the purchase of 200K shares)
- ATHX +24.7% (Athersys and Nikon CeLL innovation to collaborate on multistem commercial manufacturing in Japan)
- MBRX +8.5% (enters into an agreement to collaborate with the University of Bergen to expand research on inhibition of brain metastasis by Moleculin's pre-clinical drug WP1066)
- BTX +8.5% (reports that an investigator-led clinical trial has successfully treated its first patient in a study of Premvia)
- SLNO +5.5% (issued new U.S. patent related to the use of pharmaceutical formulations of diazoxide)
- EARS +3.2% (executes two share purchase agreements for up to $15 mln with Lincoln Park Capital)
- NBEV +2.2% (announced the expansion of Aspen Pure Probiotic throughout the more than 2,000 Ahold Delhaize (ADRNY) banner stores across 23 states)
- UVE +1.5% (UPCIC anticipates Q3 gross losses relating to Hurricane Irma will be $350-450 million; expects to recognize net pre-tax losses of only $35 million)
- ANAB +0.9% (files for 3 mln share common stock offering)
Analyst comments:
- RRC +3.3% (upgraded to Overweight from Underweight at Barclays)
- ANGI +2.7% (initiated with a Buy at Goldman)
- PYPL +1.4% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- TOUR +1.2% (initiated with a Outperform at Credit Suisse)
- CL +1% (upgraded to Buy from Hold at SunTrust)
- ABBV +0.9% (upgraded to Outperform from Market Perform at Cowen)
- V +0.6% (upgraded to Outperform from Market Perform at Wells Fargo)
- JNJ +0.5% (upgraded to Buy from Hold at Jefferies)